Close

HITK Financial Facts

DILUTED INCOME PER SHARE: 0.59
Contract research (income): 0
See Full Income Statement

Retained earnings: 182.39M
Long-term debt: 0
See Full Balance Sheet

Hi Tech Pharmacal Co. Inc. (HITK) Earnings

  |   Expand Research on HITK
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +10.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
12/5/11 Q212 $1.04$0.77 +$0.27$56.88M$51.4M N/A Details
3/8/12 Q411 $0.79$0.87 -$0.08$55.63M$55.73M N/A Details
9/7/11 Q112 $1.05$0.84 +$0.21$56.21M$54.07M N/A Details
7/7/11 Q411 $1.08$0.71 +$0.37$57.2M$49.33M N/A Details
12/9/10 Q210 $0.76$0.56 +$0.20N/AN/A N/A Details
3/10/11 Q311 $0.79$0.63 +$0.16$50M$45.33M N/A Details
7/10/12 Q412 $0.73$0.78 -$0.05$61.3M$57.94M N/A Details
9/5/12 Q113 $0.44$0.68 -$0.24$52M$57.6M N/A Details